Fig. 2From: Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fractionPlasma levels of N-Terminal pro B-type natriuretic peptide (NT-proBNP) at baseline and after 60 days of S/V treatment. Means ± se; **p < 0.01Back to article page